1. Home
  2. GAIA vs INKT Comparison

GAIA vs INKT Comparison

Compare GAIA & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$3.08

Market Cap

70.9M

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$12.19

Market Cap

70.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
INKT
Founded
1988
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.9M
70.6M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
GAIA
INKT
Price
$3.08
$12.19
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$6.50
$35.00
AVG Volume (30 Days)
53.9K
46.5K
Earning Date
05-04-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
N/A
EPS
N/A
N/A
Revenue
$4,500,000.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$12.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
12.50
N/A
52 Week Low
$2.45
$6.66
52 Week High
$6.39
$76.00

Technical Indicators

Market Signals
Indicator
GAIA
INKT
Relative Strength Index (RSI) 62.49 51.98
Support Level $2.98 $10.88
Resistance Level $3.46 $12.58
Average True Range (ATR) 0.12 1.04
MACD 0.04 -0.08
Stochastic Oscillator 100.00 30.79

Price Performance

Historical Comparison
GAIA
INKT

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. The company operates in a single reporting segment. Its revenues is derived from subscription fees for services related to streaming content to the members. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development and manufacturing of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. iNKT cells offer distinct therapeutic advantages as a platform for allogeneic therapy in that the cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host-disease. Its product candidate, agenT-797, is an off-the-shelf, allogeneic, native iNKT cell therapy. It operates its business in single segment.

Share on Social Networks: